Cargando…

Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS

SIMPLE SUMMARY: Cervical cancer is the fourth most common cancer among women worldwide, and screening programs increase its detection rate and survivability. The molecular screening of the presence of human papilloma viruses (HPV) as alternatives to physical examinations offers cost-efficient soluti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Ariadna Lara, Lindberg, Julia Hedlund, Shevchenko, Ganna, Gustavsson, Inger, Bergquist, Jonas, Gyllensten, Ulf, Enroth, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198222/
https://www.ncbi.nlm.nih.gov/pubmed/34070587
http://dx.doi.org/10.3390/cancers13112592
_version_ 1783707086434074624
author Gutiérrez, Ariadna Lara
Lindberg, Julia Hedlund
Shevchenko, Ganna
Gustavsson, Inger
Bergquist, Jonas
Gyllensten, Ulf
Enroth, Stefan
author_facet Gutiérrez, Ariadna Lara
Lindberg, Julia Hedlund
Shevchenko, Ganna
Gustavsson, Inger
Bergquist, Jonas
Gyllensten, Ulf
Enroth, Stefan
author_sort Gutiérrez, Ariadna Lara
collection PubMed
description SIMPLE SUMMARY: Cervical cancer is the fourth most common cancer among women worldwide, and screening programs increase its detection rate and survivability. The molecular screening of the presence of human papilloma viruses (HPV) as alternatives to physical examinations offers cost-efficient solutions and can be performed on self-collected samples. A persistent infection with HPV is necessary (but not sufficient) to develop cancer, and additional biomarkers are needed to increase the precision. Here, we have analysed protein biomarkers found in self-collected dried cervico–vaginal fluid (CVF) from both controls and women with cervical cancer pre-stages. Our conclusion is that protein biomarkers can be robustly detected from dried CVF and that these can aid in the detection of cervical cancer pre-stages. ABSTRACT: Molecular screening programs for cervical cancer detect the presence of human papilloma virus (HPV) in cell material or vaginal fluids. Persistent infection with high-risk HPV is a necessary pre-requisite, but the majority of infections do not lead to pathological states. Additional biomarkers are needed to increase the specificity of the molecular tests. Here, we have investigated the possibility of detecting protein biomarkers using mass spectrometry from dried self-sampled cervico–vaginal fluid deposited on FTA cards. We found significant intra-individual correlations (p < 2.2 × 10(−16)), although heterogenous protein profiles were obtained between individuals. Out of 3699 proteins found in total, 169 were detected in at least 95% of the samples. Using a discovery/replication design, 18 proteins were found to be significant in the discovery cohort, with higher values in those cases compared to controls. All of these were found to also have higher levels among the cases in the replication cohort, with one protein (DEAD-Box Helicase) remaining statistically significant. Finally, a predictive 7-protein multivariate model was developed with a sensitivity and specificity of 0.90 and 0.55, respectively. Our results demonstrate that robust measurements of protein biomarkers can be obtained from self-sampled dried CVF and that these could be used to predict cervical cancer pre-stages.
format Online
Article
Text
id pubmed-8198222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81982222021-06-14 Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS Gutiérrez, Ariadna Lara Lindberg, Julia Hedlund Shevchenko, Ganna Gustavsson, Inger Bergquist, Jonas Gyllensten, Ulf Enroth, Stefan Cancers (Basel) Article SIMPLE SUMMARY: Cervical cancer is the fourth most common cancer among women worldwide, and screening programs increase its detection rate and survivability. The molecular screening of the presence of human papilloma viruses (HPV) as alternatives to physical examinations offers cost-efficient solutions and can be performed on self-collected samples. A persistent infection with HPV is necessary (but not sufficient) to develop cancer, and additional biomarkers are needed to increase the precision. Here, we have analysed protein biomarkers found in self-collected dried cervico–vaginal fluid (CVF) from both controls and women with cervical cancer pre-stages. Our conclusion is that protein biomarkers can be robustly detected from dried CVF and that these can aid in the detection of cervical cancer pre-stages. ABSTRACT: Molecular screening programs for cervical cancer detect the presence of human papilloma virus (HPV) in cell material or vaginal fluids. Persistent infection with high-risk HPV is a necessary pre-requisite, but the majority of infections do not lead to pathological states. Additional biomarkers are needed to increase the specificity of the molecular tests. Here, we have investigated the possibility of detecting protein biomarkers using mass spectrometry from dried self-sampled cervico–vaginal fluid deposited on FTA cards. We found significant intra-individual correlations (p < 2.2 × 10(−16)), although heterogenous protein profiles were obtained between individuals. Out of 3699 proteins found in total, 169 were detected in at least 95% of the samples. Using a discovery/replication design, 18 proteins were found to be significant in the discovery cohort, with higher values in those cases compared to controls. All of these were found to also have higher levels among the cases in the replication cohort, with one protein (DEAD-Box Helicase) remaining statistically significant. Finally, a predictive 7-protein multivariate model was developed with a sensitivity and specificity of 0.90 and 0.55, respectively. Our results demonstrate that robust measurements of protein biomarkers can be obtained from self-sampled dried CVF and that these could be used to predict cervical cancer pre-stages. MDPI 2021-05-25 /pmc/articles/PMC8198222/ /pubmed/34070587 http://dx.doi.org/10.3390/cancers13112592 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gutiérrez, Ariadna Lara
Lindberg, Julia Hedlund
Shevchenko, Ganna
Gustavsson, Inger
Bergquist, Jonas
Gyllensten, Ulf
Enroth, Stefan
Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title_full Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title_fullStr Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title_full_unstemmed Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title_short Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico–Vaginal Fluid Using LC-MS/MS
title_sort identification of candidate protein biomarkers for cin2+ lesions from self-sampled, dried cervico–vaginal fluid using lc-ms/ms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198222/
https://www.ncbi.nlm.nih.gov/pubmed/34070587
http://dx.doi.org/10.3390/cancers13112592
work_keys_str_mv AT gutierrezariadnalara identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT lindbergjuliahedlund identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT shevchenkoganna identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT gustavssoninger identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT bergquistjonas identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT gyllenstenulf identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms
AT enrothstefan identificationofcandidateproteinbiomarkersforcin2lesionsfromselfsampleddriedcervicovaginalfluidusinglcmsms